EMACTUZUMAB
UNII 6FY6EI1X8R

Substance Identification & Data

This profile provides standardized clinical and technical data for Emactuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6FY6EI1X8R.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1448221-67-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6FY6EI1X8R

CAS Registry Number

1448221-67-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EMACTUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C125548

National Cancer Institute reference terminology for clinical and research data.

INN ID

9951

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

CD-102

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Emactuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EMACTUZUMAB

Common Names & Synonyms

7I1955N5WX

EMACTUZUMAB [INN]

EMACTUZUMAB [USAN]

EMACTUZUMAB [WHO-DD]

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CSF1R (COLONY STIMULATING FACTOR 1 RECEPTOR, CSF-1R, CSF-1-R, MACROPHAGE COLONYSTIMULATING FACTOR 1 RECEPTOR, C-FMS, FMS, CD115)), HUMANIZED MONOCLONAL ANTIBODY

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL LIGHT CHAIN, DIMER

SYS